HWAM
NGM
Hennion & Walsh Asset Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-70,636
| Closed | -$112K | – | 909 |
|
|
2024
Q1 | $112K | Buy |
70,636
+4,700
| +7% | +$7.47K | 0.01% | 828 |
|
|
2023
Q4 | $56.6K | Buy |
65,936
+8,069
| +14% | +$6.93K | ﹤0.01% | 816 |
|
|
2023
Q3 | $61.9K | Buy |
57,867
+2,298
| +4% | +$2.46K | ﹤0.01% | 794 |
|
|
2023
Q2 | $144K | Sell |
55,569
-1,497
| -3% | -$3.88K | 0.01% | 771 |
|
|
2023
Q1 | $233K | Sell |
57,066
-1,803
| -3% | -$7.36K | 0.01% | 706 |
|
|
2022
Q4 | $296K | Sell |
58,869
-116,314
| -66% | -$585K | 0.02% | 633 |
|
|
2022
Q3 | $2.29M | Buy |
175,183
+5,846
| +3% | +$76.5K | 0.15% | 175 |
|
|
2022
Q2 | $2.17M | Sell |
169,337
-76,985
| -31% | -$987K | 0.13% | 190 |
|
|
2022
Q1 | $3.76M | Sell |
246,322
-10,436
| -4% | -$159K | 0.2% | 140 |
|
|
2021
Q4 | $4.55M | Sell |
256,758
-20,232
| -7% | -$358K | 0.22% | 121 |
|
|
2021
Q3 | $5.82M | Sell |
276,990
-9,468
| -3% | -$199K | 0.31% | 80 |
|
|
2021
Q2 | $5.65M | Buy |
286,458
+26,617
| +10% | +$525K | 0.3% | 78 |
|
|
2021
Q1 | $7.55M | Buy |
+259,841
| New | +$7.55M | 0.45% | 40 |
|